
Sign up to save your podcasts
Or
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
4.7
181181 ratings
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
43,337 Listeners
4,202 Listeners
25,785 Listeners
86,492 Listeners
110,865 Listeners
15 Listeners
15 Listeners